Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report

Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report

Summary

Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) develops, manufactures and markets self-medication drugs and prescription pharmaceuticals. The company's self-medication products comprise over the counter (OTC) products, quasi-drugs and health food products. Its prescription pharmaceuticals portfolio includes ethical drugs in the fields of infectious diseases, orthopedic disorders, central nervous system (CNS) diseases and metabolic diseases. Taisho Pharmaceutical provide its products under Pabron, Lipovitan D, Riup, Livita, Colac, Zosyn, Clarith, Palux, Edirol, Geninax, and Lorcam brand names. The company operates through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Singapore, Taiwan and the US. Taisho Pharmaceutical is headquartered in Toshima-ku, Tokyo, Japan.

Scope

• Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
• Intelligence on Taisho Pharmaceutical Holdings Co Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Taisho Pharmaceutical Holdings Co Ltd's business structure, strategy and prospects.